Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide
Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide
Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide
Osteostatin Inhibits Collagen-Induced Arthritis by Regulation of Immune Activation, Pro-Inflammatory Cytokines, and Osteoclastogenesis
Synthesis and in vivo evaluation of a scaffold containing wollastonite/β-TCP for bone repair in a rabbit tibial defect model
Is vitamin-D supplementation not useful in patients at risk of fractures and falls?
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF).
Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia
Effects of Therapeutic Doses of Celecoxib on Several Physiological Parameters of Cultured Human Osteoblasts
The osteocyte: A multifunctional cell within the bone
Hip fractures following denosumab discontinuation: three clinical cases reports
A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients